dc.contributor.author | Williams, JA | |
dc.contributor.author | Stone, EM | |
dc.contributor.author | Fakis, G | |
dc.contributor.author | Johnson, N | |
dc.contributor.author | Cordell, JA | |
dc.contributor.author | Meinl, W | |
dc.contributor.author | Glatt, H | |
dc.contributor.author | Sim, E | |
dc.contributor.author | Phillips, DH | |
dc.date.accessioned | 2018-09-25T10:29:34Z | |
dc.date.issued | 2001-07 | |
dc.identifier | 5 | |
dc.identifier.citation | PHARMACOGENETICS, 2001, 11 pp. 373 - 388 | |
dc.identifier.issn | 0960-314X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/2856 | |
dc.identifier.doi | 10.1097/00008571-200107000-00002 | |
dc.format.extent | 373 - 388 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | |
dc.title | N-acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1097/00008571-200107000-00002 | |
rioxxterms.licenseref.startdate | 2001-07 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | PHARMACOGENETICS | |
pubs.notes | affiliation: Phillips, DH (Reprint Author), Inst Canc Res, Haddow Labs, Cotswold Rd, Sutton SM2 5NG, Surrey, England. Inst Canc Res, Haddow Labs, Sutton SM2 5NG, Surrey, England. Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England. German Inst Human Nutr, Potsdam, Germany. keywords: N-acetyltransferase; sulfotransferase; heterocyclic amines; P-32-postlabelling keywords-plus: MAMMARY EPITHELIAL-CELLS; XENOBIOTIC-METABOLIZING ENZYMES; DONE MEAT INTAKE; CANCER RISK; GENETIC POLYMORPHISMS; CIGARETTE-SMOKING; COLORECTAL-CANCER; COOKED FOODS; DNA-ADDUCTS; HEPATIC SULFOTRANSFERASES research-areas: Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy web-of-science-categories: Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy orcid-numbers: Glatt, Hansruedi/0000-0001-6053-0562 number-of-cited-references: 92 times-cited: 39 usage-count-last-180-days: 0 usage-count-since-2013: 4 journal-iso: Pharmacogenetics doc-delivery-number: 454QR unique-id: ISI:000169983700002 da: 2018-09-25 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Human Biomonitoring & Carcinogen Activation | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Human Biomonitoring & Carcinogen Activation | |
pubs.volume | 11 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Human Biomonitoring & Carcinogen Activation | en_US |
dc.contributor.icrauthor | Phillips, David Hunter | en |